At least 2,000 patients in the RECOVERY trial are expected to randomly get 150 mg of aspirin daily
Read More...
‘The role was an addition to my new group with responsibilities taken away from two of the other team members who have been doing this kind of work for quite...
Shares of Datadog (NASDAQ: DDOG) slumped 11.2% in October, according to data from S&P Global Market Intelligence. Datadog stock set a new all-time in...
CVS reported a better-than-expected 3.5% jump in third-quarter revenue, as its plan to remake the drugstore chain into a health service company paid off. Read...
Pennymac Financial was an IBD 50 leader, but stock futures and the Dow Jones today lay low ahead of the October payrolls report. Read More...
Kohl's CEO Michelle Gass joins 'Influencers with Andy Serwer' to discuss her company's strategic partnership with Amazon. Read More...
Commission-free trading platform Robinhood is an excellent heatmap of where retail investors are putting their money. Virgin Galactic is a mid-cap company that...
Odds are increasing that Biogen’s experimental and somewhat controversial Alzheimer’s disease drug may get approved after Food and Drug Administration...
All-cash 685 pence a share bid from Canada’s Intact and Denmark’s Tryg would see one of the FTSE 100’s oldest companies broken up
Read More...
Apple, Microsoft are flashing buy signals as the stock market rally fuels a breakout wave. Square leads earnings movers late. Read More...
